.jpg)
2022 NLA Scientific Sessions Abstracts
Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience.
Characterization of inclisiran use in real world: Prescription data from Germany
Presenting Author: Jason Lecocq
Authors: Raquel Lahoz, Sven Klebs, Christian Mann, Jason Lecocq, Rebecca Zingel, Divyagiri Seshagiri




Kiosk 2
A Randomized Study to Evaluate the Effect of an “Inclisiran First” Implementation Strategy vs Usual Care in Patients with Atherosclerotic Cardiovascular Disease and Elevated Low-Density Lipoprotein Cholesterol: Rationale and Design of the VICTORION-INITIATE Trial
Presenting Author: Michael Koren
Authors: Michael Koren, Cara East, Fatima Rodriguez, Robert Stoekenbroek, Dion Zappe, Peter P. Toth, Jennifer Robinson




.png)
Kiosk 2
Novel Use of Therapeutic Plasma Exchange and Evinacumab in a Patient with Homozygous Familial Hypercholesterolemia
Presenting Author: Alexandra Sykes
Authors: Amber P. Sanchez, Joseph L. Witztum, Michael J. Wilkinson




.png)
Kiosk 2
Cardiovascular risk factors in a true incident ACS population
Presenting Author: Richard Amoateng
Authors: Andrew Oehler





Kiosk 3
Unique case of management of severe hypertriglyceridemia secondary to familial chylomicronemia syndrome
Presenting Author: Sohil Golwala
Authors: Daniel Rader




Kiosk 5
Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials
Presenting Author: R. Scott Wright
Authors: Wolfgang Koenig, Kausik K Ray, David G Kallend, Ulf Landmesser, Lawrence A Leiter, Gregory G Schwartz, R Scott Wright, Lorena Garcia Conde, Mark Jaros, Frederick J Raal





Kiosk 5
Mysterious case of reduction in HDL cholesterol in a patient with B-cell monocytosis
Presenting Author: Sohil Golwala
Authors: Daniel Soffer




Kiosk 5
Racial Difference in Hypertriglyceridemia and Its Impact on Coronary Heart Diseases
Presenting Author: Kyeeun Park
Authors: N. KONINDALA, P. AUNG, K. HIMED




Kiosk 6
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10 and ORION-11, Phase III Randomized Controlled Trials
Presenting Author: R. Scott Wright
Authors: Wolfgang Koenig, Kausik K. Ray, David G. Kallend, Ulf Landmesser, Lawrence A. Leiter, Gregory G. Schwartz, R. Scott Wright, Lorena Garcia Conde, Mark Jaros, Frederick J. Raal





Kiosk 6
Eicosapentaenoic Acid (EPA) Modulates Expression of Inflammatory Proteins in Pulmonary Endothelial Cells following Exposure to Air Pollution Particle Matter
Presenting Author: RP Mason
Authors: Peter Libby, Deepak L. Bhatt, R. Preston Mason





Kiosk 7
Does Cholesterol Screening in Prader-Willi Syndrome Represent an Opportunity to Reduce Cardiovascular Disease Risk?
Presenting Author: Don Wilson
Authors: Emily Topham, Sani Roy, MD, Luke Hamilton, MS, Don Wilson, MD





Kiosk 7
Coronary Computed Tomography Angiography Evaluation of Plaque Morphology and its Relationship to HDL and Total Cholesterol to HDL Ratio
Presenting Author: Venkat Sanjay Manubolu
Authors: Dhiran Verghese, Luay Alalawi, April Kinninger, Jairo Aldana Bitar, Francesca Calicchio, Christopher Dailing, Khadije Ahmad, Ferdinand Flores, Sion K Roy, Matthew J. Budoff.

Kiosk 8
Unveiling Compound Heterozygous Familial Hypercholesterolemia
Presenting Author: Sohil Golwala
Authors: Daniel Soffer




Kiosk 8
Effects Of Icosapent Ethyl On Plasma Ceramides And Coronary Plaque Progression In EVAPORATE Trial
Presenting Author: Matthew Ito
Authors: Suvasini Lakshmanan, Lakshmanan S; Benanzer TM; Meeusen J; Donato L; Bhatt DL; Kinninger A; Golub I; Kopecky S; Hyun MC; Scott CG; Nelson JR; Budoff MJ; Ito MK; Jaffe AS; Vasile VC





Kiosk 9
Why are Patients Presenting with STEMI Already on Statin not Treated with Additional Aggressive Lipid lowering agents?
Presenting Author: Edward Gill
Authors: Francis Zirille, Michael Morcos, Steve Simon, David Saxon





Kiosk 11
Barriers and Facilitators to Identification, Cascade Testing, and Treatment for Familial Hypercholesterolemia: A Scoping Review
Presenting Author: Laney Jones
Authors: Gabriela Rodriguez, BS1,2; Evan M. Calvo, BA1,2; Nicole L. Walters, BS2; Andrew Brangan, BS2; Catherine D. Ahmed, MBA3; Mary P. McGowan, MD3,4; Alanna K. Rahm, PhD2; Amy C. Sturm, MS2,5; Laney K. Jones, PharmD, MPH2,6




Kiosk 11
Genetic Testing in Hypertriglyceridemia in Academic Lipid Clinics – Implication for Precision Medicine.
Presenting Author: Matthew Deshotels
Authors: Trevor D. Hadley, MD, Mendel Roth, PhD, Ali M. Agha, MD, Vishnu Priya Pulpati, MD, Anne K. Nugent, MPH, Salim S. Virani, MD, PhD, Vijay Nambi, MD, PhD, Patrick M. Moriarty, MD, Michael H. Davidson, MD, Christie M. Ballantyne, MD





Kiosk 12
Marked Hypoleptinemia Precedes Overt Fat Loss In Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy
Presenting Author: Maheswaran Dhanasekaran
Authors: Rashi Sandooja MD, Alexandra S. Higgins MD, Vinaya Simha MD





Kiosk 12
The Effect Of CSL112 (Apolipoprotein A-I [Human]) On Cholesterol Efflux Capacity: A Cross-study Comparison
Presenting Author: Serge Korjian
Authors: Bo Zheng, Shinya Goto, Regina Clementi, John Feaster, Danielle Duffy, Penelope Dalitz, Jolanta Airey, John Roberts, Serge Korjian, C. Michael Gibson

Kiosk 13
Socioeconomic Disparities in Dyslipidemia and Associated Complications
Presenting Author: Kyeeun Park
Authors: N. KONINDALA, P. AUNG





Kiosk 13
GOULD EDU: Primary Results of a Cluster-Randomized Trial of an Educational Intervention to Improve Guideline Adherence and Intensification of Lipid-Lowering Therapy
Presenting Author: Christie Ballantyne
Authors: Mikhail N. Kosiborod MD, Christie M. Ballantyne MD, Deepak L. Bhatt MD MPH, James A. de Lemos MD, Qi Gao MS, Naishu Kui MS, Robert S. Rosenson MD, Katherine E. Mues PhD MPH, Jason Exter PharmD, Shushama Alam PharmD, Christopher P. Cannon MD




Kiosk 15
Association Between Dietary Fat Content and Serum Lipoprotein(a) Level
Presenting Author: Nimai Patel
Authors: Eric Brandt





Kiosk 15
Effects Of Icosapent Ethyl On Plasma Ceramides And Coronary Plaque Progression In EVAPORATE Trial
Presenting Author: Suvasini Lakshmanan
Authors: Lakshmanan S; Benanzer TM; Meeusen J; Donato L; Bhatt DL; Kinninger A; Golub I; Kopecky S; Hyun MC; Scott CG; Nelson JR; Budoff MJ; Ito MK; Jaffe AS; Vasile VC





Kiosk 15
An Unsolved Case: FH or Sitosterolemia?
Presenting Author: Juliette Logan
Authors: Michael Parker Ayers, MD




